NanoVibronix, Inc. (56R0.SG)

0,6850 -0,0050 (-0,72%) Al cierre: 08:12AM CEST

NanoVibronix, Inc.

525 Executive Boulevard
Elmsford, NY 10523
United States
914 233 3004
https://www.nanovibronix.com

Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 10

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Brian M. Murphy	CEO & Director	320,12k	N/A	1957
Mr. Stephen R. Brown CPA	Chief Financial Officer	258,44k	N/A	1956
Dr. Harold Jacob M.D.	Chief Medical Officer & Director	N/A	N/A	1954
Mr. Amir Rippel	Vice President of Marketing	N/A	N/A	N/A
Ms. Lindsey Harrison	Vice President of Sales	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

Gobierno corporativo

El ISS Governance QualityScore de NanoVibronix, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.